TERUI YASUHITO 照井康仁

… Alternative Names

Yasuhito TERUI 照井康仁

照井康仁テルイヤスヒト

TERUI Yasuhito 照井康仁

Less

Researcher Number	10285786
Other IDs	https://orcid.org/0000-0002-2147-3021
Affiliation (Current)	2025: 埼玉医科大学, 医学部, 教授
Affiliation (based on the past Project Information) *help	2021 – 2023: 埼玉医科大学, 医学部, 教授 2011: 公益財団法人がん研究会, がん化学療法センター臨床部, 研究員 2005: JAPANESE FOUNDATION FOR CANCER RESEARCH, RESEARCHER, 癌化学療法センター臨床部, 副部長 2004: 財団法人癌研究会, 癌化学療法センター・臨床部, 研究員 2000: 自治医大, 医学部, 講師 1997 – 1999: 自治医科大学, 医学部, 講師
Review Section/Research Field	Principal Investigator Hematology / Basic Section 54010:Hematology and medical oncology-related / Hematology Except Principal Investigator Hematology / Clinical oncology
Keywords	Principal Investigator K562 / GFP-SUMO-1 / SUMO foci / SUMO-1 / 内皮細胞型IL-8 / アポトーシス誘導因子 / B細胞性腫瘍 / 次世代シークエンサー / Virome / Virome解析 … More / ウイルス / 多発性骨髄腫 / 悪性リンパ腫 / B細胞腫瘍 / molecular target / apoptosis / anti-cancer drugs / 核内保持 / 転写活性 / NFAT1 / SUMO修飾 / 分子標的 / アポトーシス / 抗癌剤 / N末端ペプチド / in vivo効果 / 内皮細胞 … More Except Principal Investigator アポトーシス / FAP-1 / 抗腫瘍効果 / 白血病 / インターロイキン8 / 内皮細胞 / purging tumor cells / aminopeptidase N / endothelial IL-8 / apoptosis / 腫瘍細胞除去 / アミノペプチダーゼ / 内皮細胞由来インターロイキン8 / 細胞死 / T cell leukemia / endothelial cell derived interleukin-8 / Apoptosis / HIV / シグナル伝達 / Fas / Fasリガンド / T細胞性白血病 / 末梢循環腫瘍細胞 / スフェロイド / Her2 / FISH / 蛍光免疫染色 / 末梢循環癌細胞 / 内皮型IL-8 / SLAP(Src-like adaptor protein) / retinoic acid / 分化誘導 Less

Viral Discovery and Clinical Application for B-Cell TumorsPrincipal Investigator
- Principal Investigator
  
  Yasuhito TERUI
- Project Period (FY)
  2021 – 2023
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 54010:Hematology and medical oncology-related
- Research Institution
  Saitama Medical University
細胞トモグラフィーによる分子標的治療効果相関マーカーの探索
- Principal Investigator
  
  三嶋雄二
- Project Period (FY)
  2011 – 2012
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Clinical oncology
- Research Institution
  Japanese Foundation For Cancer Research
Analysis and characterization of sumoylation substrates in anti-cancer drugs-related apoptosisPrincipal Investigator
- Principal Investigator
  
  TERUI Yasuhito
- Project Period (FY)
  2004 – 2005
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Hematology
- Research Institution
  JAPANESE FOUNDATION FOR CANCER RESEARCH
内皮細胞との相互作用によるがん細胞のアポトーシス誘導機序の解析
- Principal Investigator
  
  畠清彦
- Project Period (FY)
  1999
- Research Category
  
  Grant-in-Aid for Scientific Research on Priority Areas (A)
- Research Institution
  Jichi Medical University
新規アポトーシス誘導因子内皮細胞型インターロイキン8の作用機序解析とその臨床応用Principal Investigator
- Principal Investigator
  
  照井康仁
- Project Period (FY)
  1999 – 2000
- Research Category
  
  Grant-in-Aid for Encouragement of Young Scientists (A)
- Research Field
  
  Hematology
- Research Institution
  Jichi Medical University
Development of treatment strategies for malignancies using novel apoptosis-inducing factors.
- Principal Investigator
  
  HATAKE Kiyohiko
- Project Period (FY)
  1998 – 2000
- Research Category
  
  Grant-in-Aid for Scientific Research (B).
- Research Field
  
  Hematology
- Research Institution
  Japanese Foundation for Cancer Research
  Jichi Medical University
白血病細胞の分化により発現する新規SLAPと分化制御の解析
- Principal Investigator
  
  HATAKE Kiyohiko
- Project Period (FY)
  1997
- Research Category
  
  Grant-in-Aid for Scientific Research on Priority Areas
- Research Institution
  Jichi Medical University
白血病細胞の新しいアポトーシス誘導因子の精製とその遺伝子クローニング及び臨床応用Principal Investigator
- Principal Investigator
  
  照井康仁
- Project Period (FY)
  1997 – 1998
- Research Category
  
  Grant-in-Aid for Encouragement of Young Scientists (A)
- Research Field
  
  Hematology
- Research Institution
  Jichi Medical University
Analysis of FAP-1 gene undegoing prevention of apoptosis
- Principal Investigator
  
  HATAKE Kiyohiko
- Project Period (FY)
  1996 – 1998
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Hematology
- Research Institution
  Jichi Medical School

All 2012 2011 2006 2005 2004

All Journal Article Presentation

[Journal Article] High reproducible ADCC analysis revealed a competitive relation between ADCC and CDC and differences between FcγRllla polymorphism.2012
- Author(s)
  Mishima Y, Terui Y, Mishima Y, Kuniyoshi R, Matsusaka S, Mikuniya M, Kojima K, Hatake K.
- Journal Title
  
  Int Immunol.
  
  Volume: (on line) Issue: 8 Pages: 477-483
- DOI
  10.1093/intimm/dxs048
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23501320
[Journal Article] Circulating tumor cells as a surrogate marker for determining response to chemotherapy in Japanese patients with metastatic colorectal cancer.2011
- Author(s)
  Matsusaka S, Suenaga M, Mishima Y, Kuniyoshi R. Takagi K, Terui Y, Mizunuma N, Hatake K.
- Journal Title
  
  Cancer Sci.
  
  Volume: 102(6) Issue: 6 Pages: 1188-92
- DOI
  10.1111/j.1349-7006.2011.01926.x
- NAID
  10029294517
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23501320
[Journal Article] Circulating endothelial progenitors and CXCR4-positive circulating endothelial cells are predictive markers for bevacizumab.2011
- Author(s)
  Matsusaka S, Mishima Y, Suenaga M, Terui Y, Kuniyoshi R, Mizunuma N, Hatake K.
- Journal Title
  
  Cancer
  
  Volume: 117(17) Issue: 17 Pages: 4026-32
- DOI
  10.1002/cncr.25977
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23501320
[Journal Article] The identification of irreversible rituximab-resistant lymphoma caused by CD20 gene mutations2011
- Author(s)
  Y Mishima, Y Terui, K Takeuchi, Y Matsumoto-Mishima, S Matsusaka, R Utsubo-Kuniyoshi, K Hatake
- Journal Title
  
  Blood Cancer Journal
  
  Volume: 1 Issue: 4 Pages: e15-e15
- DOI
  10.1038/bcj.2011.11
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23501320
[Journal Article] Differential Regulation of Eotaxin-1/CCL11 and Eotaxin-3/CCL26 Production by the TNF-a and IL-4 stimulated Human Lung Fibroblast.2006
- Author(s)
  Rokudai A, Terui Y, Kuniyoshi R, Mishima Y, Mishima Y, Aizu-Yokota Y, Sonoda Y, Kasahara T, Hatake K
- Journal Title
  
  Biol.Pharm.Bull. 29(in press)
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-16590966
[Journal Article] Differential Regulation of Eotaxin-1/CCL11 and Eotaxin-3/CCL26 Production by the TNF-a and IL-4 stimulated Human Lung Fibroblast.2006
- Author(s)
  Rokudai A, Terui Y, Kuniyoshi R, Mishima Y, Mishima Y, Aizu-Yokota Y, Sonoda Y, Kasahara T, Hatake K
- Journal Title
  
  Biol. Pharm. Bull. 29(In press)
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-16590966
[Journal Article] Blockade of bulky lymphoma-associated CD55 expression by RNA interference overcomes resistance to CDC with rituximab.2006
- Author(s)
  Terui Y, Sakurai T, Mishima Y, Mishima Y, Sugimura N, Sasaoka C, Kojima K, Yokoyama M, Mizunuma N, Takahashi S, Ito Y, Hatake K
- Journal Title
  
  Cancer Science. 97
  
  Pages: 72-79
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-16590966
[Journal Article] Differential Regulation of Eotaxin-1/CCL11 and Eotaxin-3/CCL26 Production by the TNF-a and IL-4 stimulated Human Lung Fibroblast.2006
- Author(s)
  Rokudai A, Terui Y, Kuniyoshi R, Mishima Y, Mishima Y, Aizu-Yokota Y, Sonoda Y, Kasahara T, Hatake K
- Journal Title
  
  Biol.Pharm.Bull. 29(In press)
- Data Source
  KAKENHI-PROJECT-16590966
[Journal Article] Blockade of bulky lymphoma-associated CD55 expression by RNA interference overcomes resistance to CDC with rituximab.2006
- Author(s)
  Terui Y, Sakurai T, Mishima Y, Mishima Y, Sugimura N, Sasaoka C, Kojima K, Yokoyama M, Mizunuma N, Takahashi S, Ito Y, Hatake K
- Journal Title
  
  Cancer Science 97(1)
  
  Pages: 72-79
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-16590966
[Journal Article] Element array by scanning X-ray fluorescence microscopy after cis-diamminedichloro-platinum (II) treatment.2005
- Author(s)
  Shimura M, Saito A, Matsuyama S, Sakuma T, Terui Y, Ueno K, Yumoto H, Yamauchi K, Yamamura K, Mimura H, Sano Y, Yabashi M, Tamasaku K, Nishio K, Nishino Y, Endo K, Hatake K, Mori Y, Ishizaka Y, Ishikawa T:
- Journal Title
  
  Cancer Res 65
  
  Pages: 4998-5002
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-16590966
[Journal Article] Element array by scanning X-ray fluorescence microscopy after cis-diamminedichloro-platinum (II) treatment.2005
- Author(s)
  Shimura M, Saito A, Matsuyama S, Sakuma T, Terui Y, Ueno K, Yumoto H, Yamauchi K, Yamamura K, Mimura H, Sano Y, Yabashi M, Tamasaku K, Nishio K, Nishino Y, Endo K, Hatake K, Mori Y, Ishizaka Y, Ishikawa T
- Journal Title
  
  Cancer Res. 65
  
  Pages: 4998-5002
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-16590966
[Journal Article] Element array by scanning X-ray fluorescence microscopy after cis-diamminedichloro-platinum (II) treatment.2005
- Author(s)
  Shimura M, Saito A, Matsuyama S, Sakuma T, Terui Y, Ueno K, Yumoto H, yamauchi K, Yamamura K, Mimura H, Sano Y, Yabashi M, Tamasaku K, Nishio K, Nishino Y, Endo K, Hatake K, Mori Y, Ishizaki Y, Ishikawa T
- Journal Title
  
  Cancer Res 65
  
  Pages: 4998-5002
- Data Source
  KAKENHI-PROJECT-16590966
[Journal Article] Combination chemotherapy, CADO-CVP, with radiotherapy and stem cell support can be beneficial for adolescent and adult estheisoneuroblastoma2004
- Author(s)
  Mishima Y, Nagasaki E, Terui Y, et al.
- Journal Title
  
  Cancer. 101
  
  Pages: 1437-1444
- Data Source
  KAKENHI-PROJECT-16590966
[Journal Article] Dual role of sumoylation in the nuclear localization and transcriptional activation of NFAT12004
- Author(s)
  Terui Y. et al.
- Journal Title
  
  Journal of Biological Chemistry 279
  
  Pages: 28257-28265
- Data Source
  KAKENHI-PROJECT-16590966
[Presentation] Detection of rituximab resistant CD20 mutations and the elucidation of the mechanisms to develop resistant phenotype2011
- Author(s)
  三嶋雄二、照井康仁、竹内賢吾、三嶋裕子、国吉良子、畠清彦
- Organizer
  日本癌学会
- Place of Presentation
  名古屋、愛知県
- Year and Date
  2011-10-03
- Data Source
  KAKENHI-PROJECT-23501320
[Presentation] Development of a screening strategy for detecting rituximab-resistant mutations and characterization of mechanisms for acquiring resistant phenotype2011
- Author(s)
  Yuji Mishima, Yasuhito Terui, Yuko Mishima, Mariko Mikuniya, Kiyohiko Hatake
- Organizer
  Molecular Target and Cancer Therapeutics
- Place of Presentation
  SanFrancisco, CA, USA
- Year and Date
  2011-11-14
- Data Source
  KAKENHI-PROJECT-23501320
[Presentation] Genetic analysis of circulating tumor cells using 3D immunostain and FISH2011
- Author(s)
  Yuji Mishima, Satoshi Matsusaka, Yasuhito Terui, Mariko Mikuniya, Nobuyuki Mizunuma, and Kiyohiko Hatake
- Organizer
  American Association for Cancer Research
- Place of Presentation
  Orlando, FL, USA
- Data Source
  KAKENHI-PROJECT-23501320
[Presentation] Genetic analysis of circulating tumor cells using 3D immune stain and FISH2011
- Author(s)
  Yuji Mishima, Satoshi Matsusaka, Yasuhito Terui, Mariko Mikuniya, Nobuyuki Mizunuma, Kiyohiko Hatake
- Organizer
  American Association for Cancer Research
- Place of Presentation
  Orlando, FL, USA
- Year and Date
  2011-04-05
- Data Source
  KAKENHI-PROJECT-23501320

1. HATAKE Kiyohiko (80192699)

# of Collaborated Projects: 4 results

# of Collaborated Products: 0 results
2. TOMIZUKA Hiroshi (00285785)

# of Collaborated Projects: 4 results

# of Collaborated Products: 0 results
3. OHTSUKI Tetuya (60275691)

# of Collaborated Projects: 3 results

# of Collaborated Products: 0 results
4. 三嶋雄二 (10442550)

# of Collaborated Projects: 1 results

# of Collaborated Products: 8 results
5. 松阪諭 (00372665)

# of Collaborated Projects: 1 results

# of Collaborated Products: 6 results
6. 星野充明 (70275692)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
7. 角田純一 (20245054)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
8. YAMADA Muneo

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
9. 池田正幸

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results

TERUI YASUHITO 照井 康仁

Yasuhito TERUI 照井 康仁

照井 康仁 テルイ ヤスヒト

TERUI Yasuhito 照井 康仁

Research Projects

Research Products

Co-Researchers

Viral Discovery and Clinical Application for B-Cell TumorsPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

細胞トモグラフィーによる分子標的治療効果相関マーカーの探索

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Analysis and characterization of sumoylation substrates in anti-cancer drugs-related apoptosisPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

内皮細胞との相互作用によるがん細胞のアポトーシス誘導機序の解析

Principal Investigator

Project Period (FY)

Research Category

Research Institution

新規アポトーシス誘導因子内皮細胞型インターロイキン8の作用機序解析とその臨床応用Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Development of treatment strategies for malignancies using novel apoptosis-inducing factors.

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

白血病細胞の分化により発現する新規SLAPと分化制御の解析

Principal Investigator

Project Period (FY)

Research Category

Research Institution

白血病細胞の新しいアポトーシス誘導因子の精製とその遺伝子クローニング及び臨床応用Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Analysis of FAP-1 gene undegoing prevention of apoptosis

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] High reproducible ADCC analysis revealed a competitive relation between ADCC and CDC and differences between FcγRllla polymorphism.2012

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Circulating tumor cells as a surrogate marker for determining response to chemotherapy in Japanese patients with metastatic colorectal cancer.2011

Author(s)

Journal Title

DOI

NAID

Data Source

[Journal Article] Circulating endothelial progenitors and CXCR4-positive circulating endothelial cells are predictive markers for bevacizumab.2011

Author(s)

Journal Title

DOI

Data Source

[Journal Article] The identification of irreversible rituximab-resistant lymphoma caused by CD20 gene mutations2011

Author(s)

Journal Title

DOI

Data Source

TERUI YASUHITO 照井康仁

Yasuhito TERUI 照井康仁

照井康仁テルイヤスヒト

TERUI Yasuhito 照井康仁